Obstructive Sleep Apnoea Syndrome as a Systemic Low-Grade Inflammatory Disorder

  1. Zamarrón, Carlos 2
  2. Morete, Emilio 2
  3. Campo Matias, Felix del 1
  1. 1 Universidad de Valladolid
    info

    Universidad de Valladolid

    Valladolid, España

    ROR https://ror.org/01fvbaw18

  2. 2 Universidade de Santiago de Compostela
    info

    Universidade de Santiago de Compostela

    Santiago de Compostela, España

    ROR https://ror.org/030eybx10

Llibre:
Cardiovascular Risk Factors

Any de publicació: 2012

Tipus: Capítol de llibre

DOI: 10.5772/32376 GOOGLE SCHOLAR lock_openAccés obert editor

Objetivos de desarrollo sostenible

Resum

Though clinically recognized for more than four decades (Gastaut et al., 1965), general awareness of OSAS has been slow to develop. OSAS has been associated with cardiovascular disease (Marin et al., 2005; Duran-Cantolla et al., 2010; Barbe et al., 2010), automobile accidents (Teran-Santos et al., 1999), chronic obstructive pulmonary disease (Chaouat et al., 1995), heart failure (Oldenburg et al., 2007) and health related quality of life deterioration (Pichel et al., 2004). OSAS often coexists with obesity and has been related to insulin resistance and metabolic syndrome (Choi et al., 2008).